Assessment of Autonomic Regulation During the Listening of Mother Heart Beat in Newborns (Cardio_Sound)

Prematurity birth lead to an early breaking link with the in utero environment. A special attention is brought in the neonatal intensive care units to reduce noise and lighting surrounding aiming to protect the newborn.

During the uterine life fetus benefits previously of several auditory stimulations by the maternal voice, the mother's heartbeat. After birth the auditory environment is dramatically modified.

Aim of this study is to submit to the newborn an audio recording of his mother's heart beat to analyze the comfort, stress and autonomic response. Heart rate variability (HRV) analysis is a non-invasive tool able to consider autonomic nervous system activity. Previous studies have shown that pleasant feelings are associated with an increase of high frequencies variations index (HFnu index) reflecting a prevalence of parasympathetic activity in the sympathetic-parasympathetic balance. This one can be simply assess by a monitor named NIPΣ and can provide a comfort index by quantifying the parasympathetic tone.

Study Overview

Detailed Description

The study will imply 40 preterm and term newborns hospitalized in neonatal intensive care units of the University Hospital of Saint-Etienne (France).

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Étienne, France
        • CHU SAINT-ETIENNE

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 days to 1 week (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Newborn birth between 28 and 40 Weeks of Gestational Age (wGA) will be included.

Description

Inclusion Criteria:

  • Neonates between 28 and 40 Weeks of Gestational Age (wGA)
  • Hospitalized in the neonatal intensive care units of the university hospital of Saint-Etienne (France)

Exclusion Criteria:

  • Respiratory or hemodynamic instability
  • Uncontrolled sepsis
  • Sedation on going
  • Treatment known to modify the sympathetic or parasympathetic activity of the autonomic nervous system
  • Congenital disease
  • Congenital ear pathology

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Newborn birth between 28 and 40 Weeks of Gestational Age (wGA)

Newborn birth between 28 and 40 Weeks of Gestational Age (wGA) will be included. The mother's newborn will be have a record of her heartbeats.

The newborn will be have an acoustic listening of their mother's heartbeat and a record of their own heartbeats.

Record of maternal heart sounds (heartbeats) with an electronic stethoscope during 10 minutes.
Other Names:
  • Littmann® Electronic 3200
Each newborn included will have 20 minutes of an acoustic listening of their mother heartbeats previously recorded.

Recording of the newborn's heart rate: one hour before the acoustic listening, during the acoustic listening and one hour after the acoustic listening .

The variations of the autonomic nervous system will be analyzed.

An coupled Heart rate variability recording (ECG signal obtained from a Philips® IntelliVue MX700 monitor) and NIPΣ index of comfort (MDMS® NIPΣ monitor) will be used.

Other Names:
  • Philips® IntelliVue MX700 monitor; MDMS® NIPΣ monitor

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NIPΣ index
Time Frame: During the acoustic listening

Analyze variations of the activity of the autonomic nervous system (R-R cardiac interval)

NIPΣ index (from 0 to 100) obtained from an MDoloris® monitor.

The base line is measured one hour before

During the acoustic listening

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HFnu (normalized high frequency) index.
Time Frame: During the acoustic listening

Measured by analyze of record's of newborn heart rate.

The base line is measured one hour before

During the acoustic listening
HFnu (normalized high frequency) index.
Time Frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate.
One hour after the acoustic listening
Standard deviation of all NN intervals (SDNN)
Time Frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate
During the acoustic listening
Standard deviation of all NN intervals (SDNN)
Time Frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate
One hour after the acoustic listening
Proportion of NN50 divided by the total number of NN intervals (pNN50)
Time Frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate
During the acoustic listening
Proportion of NN50 divided by the total number of NN intervals (pNN50)
Time Frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate
One hour after the acoustic listening
Root mean square of the successive differences (RMSSD).of RR interval
Time Frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate.
One hour after the acoustic listening
Root mean square of the successive differences (RMSSD).of RR interval
Time Frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
During the acoustic listening
Total power spectrum (Ptot)
Time Frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
During the acoustic listening
Total power spectrum (Ptot)
Time Frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate.
One hour after the acoustic listening
Low Frequency (LF)
Time Frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
During the acoustic listening
Low Frequency (LF)
Time Frame: One hour the acoustic listening
Measured by analyze of record's of newborn heart rate.
One hour the acoustic listening
High Frequency (HF)
Time Frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
During the acoustic listening
High Frequency (HF)
Time Frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate.
One hour after the acoustic listening
Very Low Frequency (VLF)
Time Frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
During the acoustic listening
Very Low Frequency (VLF)
Time Frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate.
One hour after the acoustic listening
Ratio Low Frequency (LF) / High Frequency (HF)
Time Frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
During the acoustic listening
Ratio Low Frequency (LF) / High Frequency (HF)
Time Frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate.
One hour after the acoustic listening
Heart rate (bpm)
Time Frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
During the acoustic listening
Oxygen saturation (%)
Time Frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
During the acoustic listening
NIPΣ index
Time Frame: One hour after the acoustic listening

Analyze variations of the activity of the autonomic nervous system (R-R cardiac interval)

NIPΣ index (from 0 to 100) obtained from an MDoloris® monitor.

One hour after the acoustic listening

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 23, 2021

Primary Completion (Actual)

June 27, 2021

Study Completion (Actual)

June 27, 2021

Study Registration Dates

First Submitted

March 25, 2021

First Submitted That Met QC Criteria

March 25, 2021

First Posted (Actual)

March 29, 2021

Study Record Updates

Last Update Posted (Actual)

September 10, 2021

Last Update Submitted That Met QC Criteria

September 9, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature Birth

Clinical Trials on electronic stethoscope

3
Subscribe